Nodular lymphocyte predominant Hodgkin lymphoma (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Nodular lymphocyte predominant Hodgkin lymphoma" in English language version.

refsWebsite

Global rank English rank

4^th place

4^th place

2^nd place

2^nd place

5semanticscholar.org

11^th place

8^th place

2haematologica.org

low place

low place

5^th place

5^th place

1sciencedirect.com

149^th place

178^th place

1cancertreatmentreviews.com

low place

low place

1archivesofpathology.org

low place

low place

1pathologyoutlines.com

low place

low place

low place

low place

1,045^th place

746^th place

1web.archive.org

1^st place

1^st place

18^th place

17^th place

1redjournal.org

low place

low place

1tandfonline.com

507^th place

429^th place

archivesofpathology.org

Smith LB (2010). "Nodular Lymphocyte Predominant Hodgkin Lymphoma: Diagnostic Pearls and Pitfalls". Archives of Pathology & Laboratory Medicine. 134 (10): 1434–1439. doi:10.5858/2010-0207-OA.1. PMID 20923296.

cancertreatmentreviews.com

Saini KS, Azim HA Jr, Cocorocchio E, Vanazzi A, Saini ML, Raviele PR, Pruneri G, Peccatori FA (2011). "Rituximab in Hodgkin lymphoma: Is the target always a hit?". Cancer Treat Rev. 37 (5): 385–90. doi:10.1016/j.ctrv.2010.11.005. PMID 21183282.

doi.org

Renné C, Martín-Subero JI, Hansmann ML, Siebert R (August 2005). "Molecular Cytogenetic Analyses of Immunoglobulin Loci in Nodular Lymphocyte Predominant Hodgkin's Lymphoma Reveal a Recurrent IGH-BCL6 Juxtaposition". J Mol Diagn. 7 (3): 352–6. doi:10.1016/S1525-1578(10)60564-8. PMC 1867541. PMID 16049307.
Wang, Hao-Wei; Balakrishna, Jayalakshmi P; Pittaluga, Stefania; Jaffe, Elaine S. (January 2019). "Diagnosis of Hodgkin Lymphoma in the Modern Era". British Journal of Haematology. 184 (1): 45–59. doi:10.1111/bjh.15614. ISSN 0007-1048. PMC 6310079. PMID 30407610.
Stier JR, Vasquez RJ (2015). "Lymphocyte-Predominant Hodgkin's Disease in Children: A Case Study and Review of the Literature". Case Reports in Oncological Medicine. 2015: 351431. doi:10.1155/2015/351431. PMC 4388010. PMID 25878913.
Eichenauer, Dennis A.; Engert, Andreas (2020-12-24). "How I treat nodular lymphocyte-predominant Hodgkin lymphoma". Blood. 136 (26): 2987–2993. doi:10.1182/blood.2019004044. ISSN 0006-4971. PMID 32877522. S2CID 221476874.
Saini KS, Azim HA Jr, Cocorocchio E, Vanazzi A, Saini ML, Raviele PR, Pruneri G, Peccatori FA (2011). "Rituximab in Hodgkin lymphoma: Is the target always a hit?". Cancer Treat Rev. 37 (5): 385–90. doi:10.1016/j.ctrv.2010.11.005. PMID 21183282.
Wlodarska I, Nooyen P, Maes B, et al. (January 2003). "Frequent occurrence of BCL6 rearrangements in nodular lymphocyte predominance Hodgkin lymphoma but not in classical Hodgkin lymphoma". Blood. 101 (2): 706–10. doi:10.1182/blood-2002-05-1592. PMID 12393409.
Strobbe L, Valke LL, Diets IJ, van den Brand M, Aben K, Raemaekers KJ, Hebeda KM, van Krieken JH (2016). "A 20-year population-based study on the epidemiology, clinical features, treatment, and outcome of nodular lymphocyte predominant Hodgkin lymphoma". Ann Hematol. 95 (3): 417–423. doi:10.1007/s00277-015-2578-6. PMC 4742486. PMID 26732883.
Rets AV, Gottesman SR (2014). "Nodular Lymphocyte Predominant Hodgkin Lymphoma versus T-Cell/Histiocyte-Rich Large B-Cell Lymphoma: A Diagnostic Challenge". Case Rep Pathol. 2014 (956217): 1–5. doi:10.1155/2014/956217. PMC 4109592. PMID 25110597.
Chen RC, Chin MS, Ng AK, et al. (2010). "Early-Stage, Lymphocyte-Predominant Hodgkin's Lymphoma: Patient Outcomes From a Large, Single-Institution Series With Long Follow-Up". Journal of Clinical Oncology. 1. 28 (1): 136–141. doi:10.1200/JCO.2009.24.0945. PMID 19933914.
Smith LB (2010). "Nodular Lymphocyte Predominant Hodgkin Lymphoma: Diagnostic Pearls and Pitfalls". Archives of Pathology & Laboratory Medicine. 134 (10): 1434–1439. doi:10.5858/2010-0207-OA.1. PMID 20923296.
Xing KH, Connors JM, Lai A, et al. (2014). "Advanced-stage nodular lymphocyte predominant Hodgkin lymphoma compared with classical Hodgkin lymphoma: a matched pair outcome analysis". Blood. 123 (23): 3567–3573. doi:10.1182/blood-2013-12-541078. PMID 24713929. S2CID 25058.
Biasoli I, Stamatoullas A, Meignin V, et al. (2010). "Nodular, lymphocyte-predominant Hodgkin lymphoma". Cancer. 116 (3): 631–639. doi:10.1002/cncr.24819. PMID 20029973. S2CID 25570848.
Lazarovici J, Dartigues P, Brice P, et al. (December 2015). "Nodular lymphocyte predominant Hodgkin lymphoma: a Lymphoma Study Association retrospective study". Haematologica. 100 (12): 1579–1586. doi:10.3324/haematol.2015.133025. PMC 4666334. PMID 26430172.
Solanki AA, LeMieux MH, Chiu BC, et al. (2013). "Long-Term Outcomes in Patients with Early Stage Nodular Lymphocyte-Predominant Hodgkin's Lymphoma Treated with Radiotherapy". PLOS ONE. 8 (9): e75336. Bibcode:2013PLoSO...875336S. doi:10.1371/journal.pone.0075336. PMC 3776776. PMID 24058675.
Gerber NK, Atoria CL, Elkin EB, Yahalom J (2015). "Characteristics and Outcomes of Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma Versus Those With Classical Hodgkin Lymphoma: A Population-Based Analysis". Int J Radiation Oncol Biol Phys. 92 (1): 76–83. doi:10.1016/j.ijrobp.2015.02.012. PMID 25863756.
Eichenauer, DA; Hartmann, S (2023). "Nodular lymphocyte-predominant Hodgkin lymphoma: current management strategies and evolving approaches to individualize treatment". Expert Review of Hematology. doi:10.1080/17474086.2023.2226859.
Schulz H, Rehwald U, Morschhauser F, et al. (2008). "Rituximab in relapsed lymphocyte-predominant Hodgkin lymphoma: long-term results of a phase 2 trial by the German Hodgkin Lymphoma Study Group (GHSG)". Blood. 111 (1): 109–11. doi:10.1182/blood-2007-03-078725. PMID 17938252. S2CID 9934281.
Kenderian SS, Habermann TM, Macon WR, et al. (2016). "Large B-cell transformation in nodular lymphocyte-predominant Hodgkin lymphoma: 40-year experience from a single institution". Blood. 127 (16): 1960–1966. doi:10.1182/blood-2015-08-665505. PMC 4841039. PMID 26837698.
Appel BE, Chen L, Buxton A, Wolden SL, Hodgson DC, Nachman JB (2012). "Impact of Low-Dose Involved-Field Radiation Therapy on Pediatric Patients with Lymphocyte-Predominant Hodgkin Lymphoma Treated with Chemotherapy: A Report from the Children's Oncology Group". Pediatr Blood Cancer. 59 (7): 1284–1289. doi:10.1002/pbc.24258. PMC 3468707. PMID 22847767.
Eichenauer DA, Engert A (2017). "R-CHOP in NLPHL: who should receive it?". Blood. 130 (4): 387–388. doi:10.1182/blood-2017-05-786301. PMID 28751354.
Olszewski AJ, Shrestha R, Cook NM (2015). "Race-specific features and outcomes of nodular lymphocyte-predominant Hodgkin lymphoma: Analysis of the National Cancer Data Base". Cancer. 121 (19): 3472–80. doi:10.1002/cncr.29527. PMID 26149294. S2CID 45005554.

haematologica.org

Achten R, Verhoef G, De Wolf-Peeters C (December 2003). "The importance of follow-up biopsies of clinically suspicious lymphadenopathy in nodular lymphocyte predominant Hodgkin's lymphoma". Haematologica. 88 (12): 1431–2. PMID 14688002.
Wlodarska I, Stul M, De Wolf-Peeters C, Hagemeijer A (August 2004). "Heterogeneity of BCL6 rearrangements in nodular lymphocyte predominant Hodgkin's lymphoma". Haematologica. 89 (8): 965–72. PMID 15339680.

harvard.edu

ui.adsabs.harvard.edu

Solanki AA, LeMieux MH, Chiu BC, et al. (2013). "Long-Term Outcomes in Patients with Early Stage Nodular Lymphocyte-Predominant Hodgkin's Lymphoma Treated with Radiotherapy". PLOS ONE. 8 (9): e75336. Bibcode:2013PLoSO...875336S. doi:10.1371/journal.pone.0075336. PMC 3776776. PMID 24058675.

nccn.org

NCCN Guidelines for Patients : NCCN Quick Guide. Hodgkin Lymphoma (Nodular Lymphocyte-Predominant HL Treatment) https://www.nccn.org/patients/guidelines/quick_guides/hodgkin/nodular_treatment/index.html#^{[permanent dead link‍]}

nih.gov

pubmed.ncbi.nlm.nih.gov

Renné C, Martín-Subero JI, Hansmann ML, Siebert R (August 2005). "Molecular Cytogenetic Analyses of Immunoglobulin Loci in Nodular Lymphocyte Predominant Hodgkin's Lymphoma Reveal a Recurrent IGH-BCL6 Juxtaposition". J Mol Diagn. 7 (3): 352–6. doi:10.1016/S1525-1578(10)60564-8. PMC 1867541. PMID 16049307.
Achten R, Verhoef G, De Wolf-Peeters C (December 2003). "The importance of follow-up biopsies of clinically suspicious lymphadenopathy in nodular lymphocyte predominant Hodgkin's lymphoma". Haematologica. 88 (12): 1431–2. PMID 14688002.
Wang, Hao-Wei; Balakrishna, Jayalakshmi P; Pittaluga, Stefania; Jaffe, Elaine S. (January 2019). "Diagnosis of Hodgkin Lymphoma in the Modern Era". British Journal of Haematology. 184 (1): 45–59. doi:10.1111/bjh.15614. ISSN 0007-1048. PMC 6310079. PMID 30407610.
Stier JR, Vasquez RJ (2015). "Lymphocyte-Predominant Hodgkin's Disease in Children: A Case Study and Review of the Literature". Case Reports in Oncological Medicine. 2015: 351431. doi:10.1155/2015/351431. PMC 4388010. PMID 25878913.
Eichenauer, Dennis A.; Engert, Andreas (2020-12-24). "How I treat nodular lymphocyte-predominant Hodgkin lymphoma". Blood. 136 (26): 2987–2993. doi:10.1182/blood.2019004044. ISSN 0006-4971. PMID 32877522. S2CID 221476874.
Saini KS, Azim HA Jr, Cocorocchio E, Vanazzi A, Saini ML, Raviele PR, Pruneri G, Peccatori FA (2011). "Rituximab in Hodgkin lymphoma: Is the target always a hit?". Cancer Treat Rev. 37 (5): 385–90. doi:10.1016/j.ctrv.2010.11.005. PMID 21183282.
Wlodarska I, Stul M, De Wolf-Peeters C, Hagemeijer A (August 2004). "Heterogeneity of BCL6 rearrangements in nodular lymphocyte predominant Hodgkin's lymphoma". Haematologica. 89 (8): 965–72. PMID 15339680.
Wlodarska I, Nooyen P, Maes B, et al. (January 2003). "Frequent occurrence of BCL6 rearrangements in nodular lymphocyte predominance Hodgkin lymphoma but not in classical Hodgkin lymphoma". Blood. 101 (2): 706–10. doi:10.1182/blood-2002-05-1592. PMID 12393409.
Strobbe L, Valke LL, Diets IJ, van den Brand M, Aben K, Raemaekers KJ, Hebeda KM, van Krieken JH (2016). "A 20-year population-based study on the epidemiology, clinical features, treatment, and outcome of nodular lymphocyte predominant Hodgkin lymphoma". Ann Hematol. 95 (3): 417–423. doi:10.1007/s00277-015-2578-6. PMC 4742486. PMID 26732883.
Rets AV, Gottesman SR (2014). "Nodular Lymphocyte Predominant Hodgkin Lymphoma versus T-Cell/Histiocyte-Rich Large B-Cell Lymphoma: A Diagnostic Challenge". Case Rep Pathol. 2014 (956217): 1–5. doi:10.1155/2014/956217. PMC 4109592. PMID 25110597.
Chen RC, Chin MS, Ng AK, et al. (2010). "Early-Stage, Lymphocyte-Predominant Hodgkin's Lymphoma: Patient Outcomes From a Large, Single-Institution Series With Long Follow-Up". Journal of Clinical Oncology. 1. 28 (1): 136–141. doi:10.1200/JCO.2009.24.0945. PMID 19933914.
Smith LB (2010). "Nodular Lymphocyte Predominant Hodgkin Lymphoma: Diagnostic Pearls and Pitfalls". Archives of Pathology & Laboratory Medicine. 134 (10): 1434–1439. doi:10.5858/2010-0207-OA.1. PMID 20923296.
Xing KH, Connors JM, Lai A, et al. (2014). "Advanced-stage nodular lymphocyte predominant Hodgkin lymphoma compared with classical Hodgkin lymphoma: a matched pair outcome analysis". Blood. 123 (23): 3567–3573. doi:10.1182/blood-2013-12-541078. PMID 24713929. S2CID 25058.
Biasoli I, Stamatoullas A, Meignin V, et al. (2010). "Nodular, lymphocyte-predominant Hodgkin lymphoma". Cancer. 116 (3): 631–639. doi:10.1002/cncr.24819. PMID 20029973. S2CID 25570848.
Lazarovici J, Dartigues P, Brice P, et al. (December 2015). "Nodular lymphocyte predominant Hodgkin lymphoma: a Lymphoma Study Association retrospective study". Haematologica. 100 (12): 1579–1586. doi:10.3324/haematol.2015.133025. PMC 4666334. PMID 26430172.
Solanki AA, LeMieux MH, Chiu BC, et al. (2013). "Long-Term Outcomes in Patients with Early Stage Nodular Lymphocyte-Predominant Hodgkin's Lymphoma Treated with Radiotherapy". PLOS ONE. 8 (9): e75336. Bibcode:2013PLoSO...875336S. doi:10.1371/journal.pone.0075336. PMC 3776776. PMID 24058675.
Gerber NK, Atoria CL, Elkin EB, Yahalom J (2015). "Characteristics and Outcomes of Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma Versus Those With Classical Hodgkin Lymphoma: A Population-Based Analysis". Int J Radiation Oncol Biol Phys. 92 (1): 76–83. doi:10.1016/j.ijrobp.2015.02.012. PMID 25863756.
Schulz H, Rehwald U, Morschhauser F, et al. (2008). "Rituximab in relapsed lymphocyte-predominant Hodgkin lymphoma: long-term results of a phase 2 trial by the German Hodgkin Lymphoma Study Group (GHSG)". Blood. 111 (1): 109–11. doi:10.1182/blood-2007-03-078725. PMID 17938252. S2CID 9934281.
Kenderian SS, Habermann TM, Macon WR, et al. (2016). "Large B-cell transformation in nodular lymphocyte-predominant Hodgkin lymphoma: 40-year experience from a single institution". Blood. 127 (16): 1960–1966. doi:10.1182/blood-2015-08-665505. PMC 4841039. PMID 26837698.
Appel BE, Chen L, Buxton A, Wolden SL, Hodgson DC, Nachman JB (2012). "Impact of Low-Dose Involved-Field Radiation Therapy on Pediatric Patients with Lymphocyte-Predominant Hodgkin Lymphoma Treated with Chemotherapy: A Report from the Children's Oncology Group". Pediatr Blood Cancer. 59 (7): 1284–1289. doi:10.1002/pbc.24258. PMC 3468707. PMID 22847767.
Eichenauer DA, Engert A (2017). "R-CHOP in NLPHL: who should receive it?". Blood. 130 (4): 387–388. doi:10.1182/blood-2017-05-786301. PMID 28751354.
Olszewski AJ, Shrestha R, Cook NM (2015). "Race-specific features and outcomes of nodular lymphocyte-predominant Hodgkin lymphoma: Analysis of the National Cancer Data Base". Cancer. 121 (19): 3472–80. doi:10.1002/cncr.29527. PMID 26149294. S2CID 45005554.

ncbi.nlm.nih.gov

Renné C, Martín-Subero JI, Hansmann ML, Siebert R (August 2005). "Molecular Cytogenetic Analyses of Immunoglobulin Loci in Nodular Lymphocyte Predominant Hodgkin's Lymphoma Reveal a Recurrent IGH-BCL6 Juxtaposition". J Mol Diagn. 7 (3): 352–6. doi:10.1016/S1525-1578(10)60564-8. PMC 1867541. PMID 16049307.
Wang, Hao-Wei; Balakrishna, Jayalakshmi P; Pittaluga, Stefania; Jaffe, Elaine S. (January 2019). "Diagnosis of Hodgkin Lymphoma in the Modern Era". British Journal of Haematology. 184 (1): 45–59. doi:10.1111/bjh.15614. ISSN 0007-1048. PMC 6310079. PMID 30407610.
Stier JR, Vasquez RJ (2015). "Lymphocyte-Predominant Hodgkin's Disease in Children: A Case Study and Review of the Literature". Case Reports in Oncological Medicine. 2015: 351431. doi:10.1155/2015/351431. PMC 4388010. PMID 25878913.
Strobbe L, Valke LL, Diets IJ, van den Brand M, Aben K, Raemaekers KJ, Hebeda KM, van Krieken JH (2016). "A 20-year population-based study on the epidemiology, clinical features, treatment, and outcome of nodular lymphocyte predominant Hodgkin lymphoma". Ann Hematol. 95 (3): 417–423. doi:10.1007/s00277-015-2578-6. PMC 4742486. PMID 26732883.
Rets AV, Gottesman SR (2014). "Nodular Lymphocyte Predominant Hodgkin Lymphoma versus T-Cell/Histiocyte-Rich Large B-Cell Lymphoma: A Diagnostic Challenge". Case Rep Pathol. 2014 (956217): 1–5. doi:10.1155/2014/956217. PMC 4109592. PMID 25110597.
Lazarovici J, Dartigues P, Brice P, et al. (December 2015). "Nodular lymphocyte predominant Hodgkin lymphoma: a Lymphoma Study Association retrospective study". Haematologica. 100 (12): 1579–1586. doi:10.3324/haematol.2015.133025. PMC 4666334. PMID 26430172.
Solanki AA, LeMieux MH, Chiu BC, et al. (2013). "Long-Term Outcomes in Patients with Early Stage Nodular Lymphocyte-Predominant Hodgkin's Lymphoma Treated with Radiotherapy". PLOS ONE. 8 (9): e75336. Bibcode:2013PLoSO...875336S. doi:10.1371/journal.pone.0075336. PMC 3776776. PMID 24058675.
Kenderian SS, Habermann TM, Macon WR, et al. (2016). "Large B-cell transformation in nodular lymphocyte-predominant Hodgkin lymphoma: 40-year experience from a single institution". Blood. 127 (16): 1960–1966. doi:10.1182/blood-2015-08-665505. PMC 4841039. PMID 26837698.
Appel BE, Chen L, Buxton A, Wolden SL, Hodgson DC, Nachman JB (2012). "Impact of Low-Dose Involved-Field Radiation Therapy on Pediatric Patients with Lymphocyte-Predominant Hodgkin Lymphoma Treated with Chemotherapy: A Report from the Children's Oncology Group". Pediatr Blood Cancer. 59 (7): 1284–1289. doi:10.1002/pbc.24258. PMC 3468707. PMID 22847767.

pathologyoutlines.com

"Pathology Outline". pathologyoutlines.com. Retrieved 2017-09-02.

redjournal.org

Gerber NK, Atoria CL, Elkin EB, Yahalom J (2015). "Characteristics and Outcomes of Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma Versus Those With Classical Hodgkin Lymphoma: A Population-Based Analysis". Int J Radiation Oncol Biol Phys. 92 (1): 76–83. doi:10.1016/j.ijrobp.2015.02.012. PMID 25863756.

sciencedirect.com

Eichenauer, Dennis A.; Engert, Andreas (2020-12-24). "How I treat nodular lymphocyte-predominant Hodgkin lymphoma". Blood. 136 (26): 2987–2993. doi:10.1182/blood.2019004044. ISSN 0006-4971. PMID 32877522. S2CID 221476874.

semanticscholar.org

api.semanticscholar.org

Eichenauer, Dennis A.; Engert, Andreas (2020-12-24). "How I treat nodular lymphocyte-predominant Hodgkin lymphoma". Blood. 136 (26): 2987–2993. doi:10.1182/blood.2019004044. ISSN 0006-4971. PMID 32877522. S2CID 221476874.
Xing KH, Connors JM, Lai A, et al. (2014). "Advanced-stage nodular lymphocyte predominant Hodgkin lymphoma compared with classical Hodgkin lymphoma: a matched pair outcome analysis". Blood. 123 (23): 3567–3573. doi:10.1182/blood-2013-12-541078. PMID 24713929. S2CID 25058.
Biasoli I, Stamatoullas A, Meignin V, et al. (2010). "Nodular, lymphocyte-predominant Hodgkin lymphoma". Cancer. 116 (3): 631–639. doi:10.1002/cncr.24819. PMID 20029973. S2CID 25570848.
Schulz H, Rehwald U, Morschhauser F, et al. (2008). "Rituximab in relapsed lymphocyte-predominant Hodgkin lymphoma: long-term results of a phase 2 trial by the German Hodgkin Lymphoma Study Group (GHSG)". Blood. 111 (1): 109–11. doi:10.1182/blood-2007-03-078725. PMID 17938252. S2CID 9934281.
Olszewski AJ, Shrestha R, Cook NM (2015). "Race-specific features and outcomes of nodular lymphocyte-predominant Hodgkin lymphoma: Analysis of the National Cancer Data Base". Cancer. 121 (19): 3472–80. doi:10.1002/cncr.29527. PMID 26149294. S2CID 45005554.

tandfonline.com

Eichenauer, DA; Hartmann, S (2023). "Nodular lymphocyte-predominant Hodgkin lymphoma: current management strategies and evolving approaches to individualize treatment". Expert Review of Hematology. doi:10.1080/17474086.2023.2226859.

web.archive.org

NCCN Guidelines v2.2014 Hodgkin Lymphoma http://williams.medicine.wisc.edu/hodgkins.pdf Archived 2020-07-09 at the Wayback Machine

wisc.edu

williams.medicine.wisc.edu

NCCN Guidelines v2.2014 Hodgkin Lymphoma http://williams.medicine.wisc.edu/hodgkins.pdf Archived 2020-07-09 at the Wayback Machine

worldcat.org

search.worldcat.org

Wang, Hao-Wei; Balakrishna, Jayalakshmi P; Pittaluga, Stefania; Jaffe, Elaine S. (January 2019). "Diagnosis of Hodgkin Lymphoma in the Modern Era". British Journal of Haematology. 184 (1): 45–59. doi:10.1111/bjh.15614. ISSN 0007-1048. PMC 6310079. PMID 30407610.
Eichenauer, Dennis A.; Engert, Andreas (2020-12-24). "How I treat nodular lymphocyte-predominant Hodgkin lymphoma". Blood. 136 (26): 2987–2993. doi:10.1182/blood.2019004044. ISSN 0006-4971. PMID 32877522. S2CID 221476874.